Melitracen
Melitracen
Melitracen (pronounced: mel-ee-truh-sen) is a tricyclic antidepressant (TCA) used primarily in the treatment of depression and anxiety disorders. It is a member of the dibenzazepine group of tricyclics, which also includes amitriptyline and imipramine.
Etymology
The term "Melitracen" is derived from the chemical structure of the compound, which is a tricyclic structure with a methyl group (mel-) and a tricyclic antidepressant (-tracen).
Usage
Melitracen is used in combination with flupentixol (a thioxanthene antipsychotic) in the treatment of mixed anxiety and depressive disorders. It works by increasing the levels of certain chemicals in the brain that help elevate mood.
Side Effects
Common side effects of Melitracen include drowsiness, dry mouth, constipation, and blurred vision. More serious side effects may include heart problems, severe constipation, and confusion.
Related Terms
- Tricyclic antidepressant (TCA)
- Dibenzazepine
- Amitriptyline
- Imipramine
- Flupentixol
- Depression
- Anxiety disorders
External links
- Medical encyclopedia article on Melitracen
- Wikipedia's article - Melitracen
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski